logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HNSCC: weekly, triweekly cisplatin similarly effective in CCRT

Systematic review of 39 studies suggests dosing should be guided by tolerability.